Literature DB >> 3862362

Purification and characterization of bile salt sulfotransferase from human liver.

L J Chen, I H Segel.   

Abstract

Bile salt sulfotransferase, the enzyme responsible for the formation of bile salt sulfate esters, was purified extensively from normal human liver. The purification procedure included DEAE-Sephadex chromatography, taurocholate-agarose affinity chromatography, and preparative isoelectrofocusing. The final preparation had a specific activity of 18 nmol min-1 mg protein-1, representing a 760-fold purification from the cytosol fraction with a overall yield of 15%. The human enzyme has a Mr of 67,000 and a pI of 5.2. DEAE-Sephadex chromatography of the cytosol fraction revealed only a single species of activity. The limiting Km for the sulfuryl donor, 3'-phosphoadenosine-5'-phosphosulfate (PAPS), is 0.7 microM. The limiting Km for the sulfuryl acceptor, glycolithocholate (GLC), is 2 microM. Reciprocal plots were intersecting. Product inhibition studies established that adenosine 3',5'-diphosphate (PAP) was competitive with PAPS (Ki = 0.2 microM) and noncompetitive with respect to GLC. GLC sulfate was competitive with GLC (Ki = 2.2 microM) and noncompetitive with respect to PAPS. Also, 3-ketolithocholate, a dead-end inhibitor, was competitive with GLC (Ki = 0.6 microM) and noncompetitive with respect to PAPS. Iso-PAP (the 2' isomer of PAP) was competitive with PAPS (Ki = 0.3 microM) and noncompetitive with GLC. The cumulative results of the steady-state kinetics experiments point to a random mechanism for the binding of substrates and release of products. The purified enzyme displays no activity toward estrone, testosterone, or phenol. Among the reactive substrates tested, the Vmax/Km values are in the order GLC greater than 3-beta OH-5-cholenic acid greater than glycochenodeoxycholate greater than glycocholate. p-Chloromercuribenzoate inactivated the enzyme. Either PAPS or GLC protected against inactivation, suggesting the presence of a sulfhydryl group at the active site.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3862362     DOI: 10.1016/0003-9861(85)90559-4

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Human liver steroid sulphotransferase sulphates bile acids.

Authors:  A Radominska; K A Comer; P Zimniak; J Falany; M Iscan; C N Falany
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

2.  Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR).

Authors:  Junichiro Sonoda; Wen Xie; John M Rosenfeld; Joyce L Barwick; Philip S Guzelian; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

3.  Isotope exchange at equilibrium indicates a steady state ordered kinetic mechanism for human sulfotransferase.

Authors:  Eduard Tyapochkin; Paul F Cook; Guangping Chen
Journal:  Biochemistry       Date:  2008-10-18       Impact factor: 3.162

4.  Purification and characterization of human liver dehydroepiandrosterone sulphotransferase.

Authors:  C N Falany; M E Vazquez; J M Kalb
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

5.  Screening for drug-induced hepatotoxicity in primary mouse hepatocytes using acetaminophen, amiodarone, and cyclosporin a as model compounds: an omics-guided approach.

Authors:  Anke Van Summeren; Johan Renes; Daneida Lizarraga; Freek G Bouwman; Jean-Paul Noben; Joost H M van Delft; Jos C S Kleinjans; Edwin C M Mariman
Journal:  OMICS       Date:  2013-01-11

Review 6.  The Effect of Lithocholic Acid on the Gut-Liver Axis.

Authors:  Wei Sheng; Guang Ji; Li Zhang
Journal:  Front Pharmacol       Date:  2022-07-07       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.